NAAG as a neurotransmitter

Advances in Experimental Medicine and Biology

Volumn 576, Issue , 2006, Pages 317-325

  Wroblewska, Barbara ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934441155     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-30172-0_23     Document Type: Conference Paper

References (58)

1. Adams B. and Moghaddam B. (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18, 5545-54.
2. Anderson K. J., Borja M. A., Cotman C. W., Moffett J. R., Namboodiri M. A., and Neale J. H. (1987) N-acetylaspartylglutamate identified in the rat retinal ganglion cells and their projections in the brain. Brain Res 411, 172-7.
3. Anderson K. J., Monaghan D. T., Cangro C. B., Namboodiri M. A., Neale J. H., and Cotman C. W. (1986) Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain. Neurosci Lett 72, 14-20.
4. Bacich D. J., Ramadan E., O'Keefe D. S., Bukhari N., Wegorzewska I., Ojeifo O., Olszewski R., Wrenn C. C., Bzdega T., Wroblewska B., Heston W. D. W., and Neale J. H. (2002) Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J Neurochem 83, 20-29.
5. Baslow M. H. (2000) Functions of N-Acetyl-L-Aspartate and N-Acetyl-L-Aspartylglutamate in the Vertebrate Brain: Role in Glial Cell-Specific Signaling. J Neurochem 75, 453-459.
6. Berent-Spillson, A., Robinson, A.M., Golovoy, D., Slusher, B., Rojas, C., and Russell, J. W. (2004) Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J Neurochem 89, 90-99.
7. Berger U. V., Carter R. E., McKee M., and Coyle J. T. (1995) N-acetylated alpha-linked acidic dipeptidase is expressed by non- myelinating Schwann cells in the peripheral nervous system. J Neurocytol 24, 99-109.
8. Bzdega T., Crowe S. L., Ramadan E. R., Sciarretta K. H., Olszewski R. T., Ojeifo O. A., Rafalski V. A., Wroblewska B., and Neale J. H. (2004) The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J Neurochem 89, 627-35.
9. Bzdega T., Turi T., Wroblewska B., She D., Chung H. S., Kim H., and Neale J. H. (1997) Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. J Neurochem 69, 2270-7.
10. Cangro C. B., Namboodiri M. A., Sklar L. A., Corigliano-Murphy A., and Neale J. H. (1987) Immunohistochemistry and biosynthesis of N- acetylaspartylglutamate in spinal sensory ganglia. J Neurochem 49, 1579-88.
11. Carpenter K. J., Sen S., Matthews E. A., Flatters S. L., Wozniak K. M., Slusher B. S., and Dickenson A. H. (2003) Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat. Neuropeptides 37, 298-306.
12. Carter R. E., Feldman A. R., and Coyle J. T. (1996) Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A 93, 749-53.
13. Cartmell J., Monn J. A., and Schoepp D. D. (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291, 161-70.
14. Cartmell J., Monn J. A., and Schoepp D. D. (2000) Tolerance to the motor impairment, but not to the reversal of PCP- induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268. Naunyn Schmiedebergs Arch Pharmacol 361, 39-46.
15. Cassidy M. and Neale J. H. (1993) N-acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia. Neuropeptides 24, 271-8.
16. Coyle J. T. (1997b) The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis 4, 231-8.
17. Curatolo A., D Arcangelo P, Lino A., and Bracanti A. (1965) Distribution of N-acetylaspartic and N-acetylaspartylglutamic acids in nervous tissue. J Neurochem 12, 339-42.
18. Fuhrman S., Palkovits M., Cassidy M., and Neale J. H. (1994) The regional distribution of N-acetylaspartylglutamate (NAAG) and peptidase activity against NAAG in the rat nervous system. J Neurochem 62, 275-81.
19. Gafurov B., Urazaev A. K., Grossfeld R. M., and Lieberman E. M. (2001) N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to- glia signaling in the crayfish medial giant nerve fiber. Neuroscience 106, 227-35.
20. Garrido Sanabria, Emilio R., Wozniak, Krystyna M., Slusher, Barbara S., and Keller, Asaf. (2004) GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic transmission by a presynaptic mechanism. J Neurophysiol 91: 182-193.
21. Israeli R. S., Powell C. T., Fair W. R., and Heston W. D. (1993) Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53, 227-30.
22. Javitt D. C. and Coyle J. T. (2004) Decoding schizophrenia. Sci Am 290, 48-55.
23. Javitt DC, and Zukin SR. (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148, 1301-8.
24. Konradi C. and Heckers S. (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97, 153-79.
25. Kozikowski A. P., Nan F., Conti P., Zhang J., Ramadan E., Bzdega T., Wroblewska B., Neale J. H., Pshenichkin S., and Wroblewski J. T. (2001) Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase). J Med Chem 44, 298-301.
26. Kozikowski A. P., Zhang J., Nan F., Petukhov P. A., Grajkowska E., Wroblewski J. T., Yamamoto T., Bzdega T., Wroblewska B., and Neale J. H. (2004) Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents. J Med Chem 47, 1729-1738.
27. Luthi-Carter R., Berger U. V., Barczak A. K., Enna M., and Coyle J. T. (1998) Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A 95, 3215-20.
28. Moffett J. R. and Namboodiri M. A. (1995) Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J Neurocytol 24, 409-33.
29. Moffett J. R., Williamson L., Palkovits M., and Namboodiri M. A. (1990) N-acetylaspartylglutamate: a transmitter candidate for the retinohypothalamic tract. Proc Natl Acad Sci U S A 87, 8065-9.
30. Moghaddam B. and Adams B. W. (1998) Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats. Science 281, 1349-1352.
31. Nan F., Bzdega T., Pshenichkin S., Wroblewski J. T., Wroblewska B., Neale J. H., and Kozikowski A. P. (2000) Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity. J Med Chem 43, 772-4.
32. Neale J. H., Bzdega T., and Wroblewska B. (2000) N- Acetylaspartylglutamate: The Most Abundant Peptide Neurotransmitter in the Mammalian Central Nervous System. J Neurochem 75, 443-452.
33. Ohishi H., Shigemoto R., Nakanishi S., and Mizuno N. (1993) Distribution of the messenger RNA for a metabotropic glutamate receptor (mGluR3) in the rat brain - an in situ hybridization study. J Comp Neurol 335, 252-266.
34. Olszewski R. T., Bukhari N., Zhou J., Kozikowski A. P., Wroblewski J. T., Shamimi-Noori S., Wroblewska B., Bzdega T., Vicini S., Barton F. B., and Neale J. H. (2004) NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem 89, 876-85.
35. Renno W. M., Lee J. H., and Beitz A. J. (1997) Light and electron microscopic immunohistochemical localization of N- acetylaspartylglutamate (NAAG) in the olivocerebellar pathway of the rat. Synapse 26, 140-54.
36. Riveros N. and Orrego F. (1984) A study of possible excitatory effects of N-acetylaspartylglutamate in different in vivo and in vitro brain preparations. Brain Res 299, 393-5.
37. Robinson M. B., Blakely R. D., Couto R., and Coyle J. T. (1987) Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha- linked acidic dipeptidase activity from rat brain. J Biol Chem 262, 14498-506.
38. Rojas C., Thomas A. G., Majer P., Tsukamoto T., Lu X. M., Vornov J. J., Wozniak K. M., and Slusher B. S. (2003) Glutamate carboxypeptidase II inhibition as a novel therapeutic target. Adv Exp Med Biol 524, 205-13.
39. Rong S. B., Zhang J., Neale J. H., Wroblewski J. T., Wang S., and Kozikowski A. P. (2002) Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors. J Med Chem 45, 4140-52.
40. Shave E., Pliss L., Lawrence M.L., FitzGibbon T., Stastny F., Balcar V.J. (2001) Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain. Neurochem International 38, 53-62
41. Slusher B. S., Robinson M. B., Tsai G., Simmons M. L., Richards S. S., and Coyle J. T. (1990) Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. J Biol Chem 265, 21297-301.
42. Slusher B. S., Tsai G., Yoo G., and Coyle J. T. (1992) Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol 315, 217-29.
43. Slusher B. S., Vornov J. J., Thomas A. G., Hurn P. D., Harukuni I., Bhardwaj A., Traystman R. J., Robinson M. B., Britton P., Lu X. C., Tortella F. C., Wozniak K. M., Yudkoff M., Potter B. M., and Jackson P. F. (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5, 1396-402.
44. Taylor, D. L., Diemel, L. T., Cuzner, M. L., and Pocock, J. M. (2002) Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J Neurochem 82, 1179-1191.
45. Taylor, D. L., Jones, F., Kubota, E. S. F. Chen S., and Pocock, J.M.(2005) Stimulation of Microglial Metabotropic Glutamate Receptor mGlu2 Triggers Tumor Necrosis Factor {alpha}-Induced Neurotoxicity in Concert with Microglial-Derived Fas Ligand. J. Neurosci. 25, 2952-2964.
46. Thomas A. G., Olkowski J. L., and Slusher B. S. (2001) Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation. Europ J Pharmacol 426, 35-38.
47. Tieman S. B., Neale J. H., and Tieman D. G. (1991) N- acetylaspartylglutamate immunoreactivity in neurons of the monkey's visual pathway. J Comp Neurol 313, 45-64.
48. Tsai G. and Coyle J.T. (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 42, 165-179.
49. Tyszkiewicz J. P., Gu Z., Wang X., Cai X., and Yan Z. (2004) Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex. J Physiol 554, 765-77.
50. Urazaev, A. K., Buttram, J. G., Deen, J. P., Gafurov, B. S., Slusher, B. S., Grossfeld, R. M., Lieberman, E. M. (2001) Mechanisms for clearance of released N-acetylaspartylglutamate in crayfish nerve fibers: Implications for axonglia signaling Neurosci 107, 697-703.
51. Williamson L. C., Eagles D. A., Brady M. J., Moffett J. R., Namboodiri M. A., and Neale J. H. (1991) Localization and Synaptic Release of N-acetylaspartylglutamate in the Chick Retina and Optic Tectum. Eur J Neurosci 3, 441-451.
52. Wroblewska B., Santi M. R., and Neale J. H. (1998) N- acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24, 172-9.
53. Wroblewska B., Wroblewski J. T., Pshenichkin S., Surin A., Sullivan S. E., and Neale J. H. (1997) N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J Neurochem 69, 174-81.
54. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J., and Neale J. H. (2004) Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci 20, 483-94.
55. Yamamoto T., Nozaki-Taguchi N., Sakashita Y., and Inagaki T. (2001) Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test. Neuroscience 102, 473-9.
56. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J., and Neale J. H. (2004) Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci 20, 483-494.
57. Zhao J., Ramadan E., Cappiello M., Wroblewska B., Bzdega T., and Neale J. H. (2001) NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance. Eur J Neurosci 13, 340-6
58. Zukin S. R. and Javitt D. C. (1989) Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research. NIDA Res Monogr 95, 247-54.